After having uncovered the clinical diagnostic and prognostic function of lncRNA XIST in CRC chemotherapy, we then investigated the experimental role of XIST of how it can exert the pro-oncogenic role for CRC chemoresistance. The gene discussed is XIST; the disease is colorectal carcinoma.